Response to saralasin and angiotensin's role in essential and renal hypertension.
D000293:Adolescent; D000328:Adult; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000097:blood* / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000209:etiology / Q000503:physiopathology*; D006977:Hypertension, Renal / Q000503:physiopathology; D008875:Middle Aged; D012083:Renin / Q000097:blood; D012504:Saralasin / Q000494:pharmacology*; D012964:Sodium / Q000378:metabolism
D000804:Angiotensin II; D012964:Sodium; D012083:Renin; D012504:Saralasin